Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis

NCT01580878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

707

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Pedis

Interventions

DRUG: Butenafine Hydrochloride Cream, 1%
DRUG: Lotrimin Ultra®
DRUG: Butenafine Vehicle

Sponsor

Sun Pharmaceutical Industries, Inc.